UA10259A - Neuropolyosm, antiedematous drug - Google Patents

Neuropolyosm, antiedematous drug

Info

Publication number
UA10259A
UA10259A UA95083679A UA95083679A UA10259A UA 10259 A UA10259 A UA 10259A UA 95083679 A UA95083679 A UA 95083679A UA 95083679 A UA95083679 A UA 95083679A UA 10259 A UA10259 A UA 10259A
Authority
UA
Ukraine
Prior art keywords
drug
neuropolyosm
antiedematous
namely
oxide
Prior art date
Application number
UA95083679A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Володимир Йосипович Луговий
Владимир Иосифович Луговый
Віктор Кузьмич Мазалов
Виктор Кузьмич Мазалов
Людмила Анатоліївна Ханіна
Людмила Анатолиевна Ханина
Володимир Михайлович Гучок
Владимир Михайлович Гучок
Сергій Євгенович Овсянніков
Сергей Евгеньевич Овсянников
Олександр Володимирович Фролов
Александр Владимирович Фролов
Юрій Георгійович Доронін
Юрий Георгиевич Доронин
Микола Павлович Юрченко
Николай Павлович Юрченко
Original Assignee
Інститут проблем кріобіології і кріомедицини НАН України
Институт Проблем Криобиологии И Криомедицины Нан Украины
Мале Підприємство "Текма"
Малое Предприятие "Текма"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут проблем кріобіології і кріомедицини НАН України, Институт Проблем Криобиологии И Криомедицины Нан Украины, Мале Підприємство "Текма", Малое Предприятие "Текма" filed Critical Інститут проблем кріобіології і кріомедицини НАН України
Priority to UA95083679A priority Critical patent/UA10259A/en
Publication of UA10259A publication Critical patent/UA10259A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the medicine, namely to the neurosurgery and may be used for treating the diseases accompanied with brain edema. The drug comprises 15% polyethylene oxide 400, namely cryopolyethylene oxide.
UA95083679A 1995-08-07 1995-08-07 Neuropolyosm, antiedematous drug UA10259A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA95083679A UA10259A (en) 1995-08-07 1995-08-07 Neuropolyosm, antiedematous drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA95083679A UA10259A (en) 1995-08-07 1995-08-07 Neuropolyosm, antiedematous drug

Publications (1)

Publication Number Publication Date
UA10259A true UA10259A (en) 1996-12-25

Family

ID=74552652

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95083679A UA10259A (en) 1995-08-07 1995-08-07 Neuropolyosm, antiedematous drug

Country Status (1)

Country Link
UA (1) UA10259A (en)

Similar Documents

Publication Publication Date Title
NO954996D0 (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
BG101118A (en) Therapeutical compounds
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
CO4290346A1 (en) Azithromycin Controlled Release Dosage Forms
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
DE69331605D1 (en) USE OF PHENSERIN FOR THE PRODUCTION OF MEDICINES FOR TREATING COGNITIVE DISORDERS
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
GB9212308D0 (en) Therapeutic compositions
WO1998026770A3 (en) The topical use of kappa opioid agonists to treat ocular pain
EP0869801A4 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
MX9707642A (en) Pharmaceutical agents for the treatment of alzheimer's disease.
EP0744176A3 (en) Methods for inhibiting bone loss
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
AU1278600A (en) Novel therapeutic application of nicergoline
AU4984493A (en) Injection for curing injured abnormal tissue, process for producing the same, and use thereof
UA10259A (en) Neuropolyosm, antiedematous drug
NZ268039A (en) Use of efaroxan in treating parkinson's disease
MX9704035A (en) Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
ZA989665B (en) The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.
MX9704036A (en) 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
CA2248753A1 (en) Use of olanzapine for treating excessive aggression